Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-05-01

Clinical Trial Update: Sunitinib and Atrial Trabeculae Contractility

View source ↗

Summary

This completed clinical trial evaluated the effect of sunitinib on atrial trabeculae contractility with focus on cardiotoxicity, ischemia, and heart failure.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sunitinib (sunitinib)

Snippet

Sponsor: Radboud University Medical Center | Conditions: Cardiotoxicity, Ischemia | Status: COMPLETED